Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted imidazo[1,2b]pyridazine compounds as Trk kinase inhibitors

Substituted imidazo[1,2b]pyridazine compounds as Trk kinase inhibitors

US Patent 8450322 · Granted May 28, 2013

Estimated economic value: $9,040,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors2024
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors2024
Fused heterocyclic compounds as RET kinase inhibitors2024
Fused heterocyclic compounds as RET kinase inhibitors2024
Protein tyrosine phosphatase inhibitors2024
Substituted pyrazolo[1,5-A]pyrazine compounds as ret kinase inhibitors2023
Substituted pyrazolo[1,5-A]pyrazine compounds as ret kinase inhibitors2023
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors2023
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors2023
Protein tyrosine phosphatase inhibitors2023
Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors2023
Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors2023